Skip to content
Homepage
Clinic directory

Clinics in El Paso, New Mexico

Every listing is checked against federal records, reviewed for evidence, and confirmed still operating. No pay-to-play. No guesswork.

  • No results found.
  • No results found.

El Paso, NM

Peptide Therapy clinics in El Paso

El Paso has a border city with cross-cultural medical demand and a Fort Bliss military population, and peptide therapy has grown into a visible slice of the local wellness market. The clinics we track across the Upper Valley, Mesa Hills, and the East Side range from physician-led longevity practices to medspa-adjacent wellness offices offering sermorelin blends and growth hormone peptides. Most local prescribers have training or admitting privileges within the Las Palmas, Del Sol, and William Beaumont Army Medical Center network. The scene here skews toward clinics serving active-duty soldiers, veterans, and cross-border patients. The regulatory landscape shifted sharply in 2023 and 2024 when the FDA placed several widely prescribed peptides on its Category 2 bulk substances list, restricting which ingredients compounding pharmacies could legally source. That changed access overnight for BPC-157, CJC-1295, ipamorelin, and thymosin beta-4. Sermorelin and tesamorelin remain FDA-approved for specific indications, and reputable El Paso clinics now draw a clearer line between approved peptides and off-label research compounds than they did two years ago.

No clinics found

Try adjusting your filters or search terms

Reset all filters

Regulatory context

A note on New Mexico's peptide therapy rules.

Most research peptides used in regenerative medicine (BPC-157, TB-500, CJC-1295, ipamorelin) are not FDA-approved drugs. Sermorelin and tesamorelin hold FDA approvals for specific indications. The FDA placed several peptides into Category 2 on its Bulk Drug Substances Nominated for Use in Compounding list during 2023 and 2024, restricting 503A pharmacy sourcing. Section 503A covers traditional patient-specific compounding; Section 503B covers FDA-registered outsourcing facilities held to cGMP.

  • New Mexico Statutes Chapter 61 Article 11 (Pharmacy Act)
    Governs pharmacy licensure and compounding under the New Mexico Board of Pharmacy.
  • New Mexico Statutes Chapter 61 Article 6 (Medical Practice Act)
    Regulates physician prescribing and delegation.
  • New Mexico Statutes Chapter 61 Article 14E (Naturopathic Doctors)
    Licenses NDs with limited prescriptive authority under a state formulary.

The New Mexico Board of Pharmacy inspects compounding pharmacies for USP 795 and USP 797 compliance. Non-resident pharmacies shipping peptides into New Mexico must hold a current non-resident pharmacy license. The Board publishes disciplinary actions.

Peptide Therapy in El Paso, answered.

El Paso clinics most commonly offer sermorelin and sermorelin plus ipamorelin blends for growth hormone support, both of which are FDA-approved for adult GH deficiency. Healing peptides like BPC-157 and thymosin beta-4 (TB-500) are sometimes offered, but neither is FDA-approved and both landed on the FDA's Category 2 bulk list in 2023, which restricts compounding pharmacy sourcing. CJC-1295 and tesamorelin (Egrifta) appear in some protocols; tesamorelin is FDA-approved for HIV-associated lipodystrophy only. Melanotan II, epithalon, and selank are not FDA-approved.

$250 to $425 per month for sermorelin or sermorelin plus ipamorelin blends. $350 to $600 per month for BPC-157 plus TB-500 protocols when available. $325 to $575 per month for peptide plus hormone optimization bundles. Expect $250 to $550 upfront for initial labs (CBC, CMP, IGF-1, hormone panel, inflammatory markers) and the intake consult. Most clinics expect a 3 to 6 month commitment with monthly or quarterly follow-ups, and injection supplies and shipping from the compounding pharmacy are usually bundled into the monthly price.

Sermorelin and tesamorelin are FDA-approved for specific indications, so those are the only peptides a Texas clinic can prescribe as standard practice with full FDA backing. BPC-157, CJC-1295, ipamorelin, thymosin beta-4 (TB-500), epithalon, melanotan, and most other research peptides are not FDA-approved. The FDA's 2023-2024 Category 2 bulk substances list decision meant 503A compounding pharmacies lost legal access to many of those ingredients, so availability fluctuates. Any El Paso clinic that still offers a long menu of non-approved peptides should disclose exactly where those ingredients come from.

Texas restricts nurse practitioner prescribing to direct physician supervision, so most peptide prescriptions are written or co-signed by an MD or DO. Physician assistants operate under delegation agreements. All compounded peptide prescriptions must be filled through a state-licensed 503A pharmacy. The Texas Medical Board licenses prescribers and the Texas State Board of Pharmacy regulates compounding, with Texas historically home to several large 503B outsourcing facilities. Peptides are typically administered by subcutaneous injection at home after a training session at the clinic, though some El Paso offices offer in-clinic injections. Be wary of non-clinical operators selling peptides labeled as research chemicals, which is a federal red flag regardless of state law.

Verify the prescribing physician's active license through the Texas medical board and confirm their NPI number through the NPPES registry. Ask which 503A compounding pharmacy supplies the peptides and whether that pharmacy is licensed in Texas. Request baseline labs (CBC, CMP, IGF-1, hormone panel, inflammatory markers) before starting any growth hormone peptide, and confirm a monitoring schedule. Reputable El Paso clinics in the Upper Valley will clearly distinguish FDA-approved peptides from off-label compounds and avoid marketing research chemicals to the public.

Filters

Rating

Treatments

Advanced Therapies 1
Chronic, Immune & Hormonal
Digestive & Respiratory
IV & Infusion
Pain & Musculoskeletal
Skin & Aesthetics
Mental Health & Neurology